Cause of the Most Devastating Pandemics in History Revealed
|
By LabMedica International staff writers Posted on 04 Feb 2014 |

Image: Tooth of one of the plague victims buried in Bavaria (Photo courtesy of McMaster University).
A new study reveals that two of the world's most devastating pandemics, the plague of Justinian and the Black Death, were caused by distinct strains of the same pathogen.
Researchers at McMaster University (Hamilton, ON, Canada), Northern Arizona University (Flagstaff, USA), the University of Sydney (Australia), and other institutions isolated miniscule DNA fragments from the 1,500 year old teeth of two victims of the Justinian plague, who were buried in the Aschheim-Bajuwarenring cemetery (Bavaria, Germany); these are the oldest pathogen genomes obtained to date. Using these short fragments, the researchers reconstructed the genome of the bacterium responsible, and compared it to a database of genomes of more than a hundred contemporary strains.
The results showed that the bacterium was a strain of Yersinia pestis, the same pathogen responsible for the Black Death. But while the strain responsible for the Justinian outbreak was an evolutionary “dead-end” and faded out on its own, the other, likely a descendant of the Black Death strain, lead to another worldwide pandemic spreading from Hong Kong across the globe in the late 1800’s. According to the researchers, these findings suggest a new strain of plague could emerge again in humans in the future. The study was published online on January 28, 2014, in the Lancet Infectious Diseases.
“About 200 rodent species carry the plague and could potentially infect other animals or humans. Scientists need to sharpen their surveillance of plague in rodent populations to try averting future human infections,” said lead author Associate Professor Hendrik Poinar, PhD, director of the McMaster Ancient DNA Center. “If we happen to see a massive die-off of rodents somewhere, then it would become alarming. Plague is something that will continue to happen, but modern-day antibiotics should be able to stop it.”
The Plague of Justinian struck in the sixth century and it is estimated to have killed between 30 and 50 million people—virtually half the world's population—as it spread across Asia, North Africa, The Arabian peninsula, and Europe. The Black Death struck some 800 years later with similar force, killing 50 million Europeans in just four years (1347-1351).
Related Links:
McMaster University
Northern Arizona University
University of Sydney
Researchers at McMaster University (Hamilton, ON, Canada), Northern Arizona University (Flagstaff, USA), the University of Sydney (Australia), and other institutions isolated miniscule DNA fragments from the 1,500 year old teeth of two victims of the Justinian plague, who were buried in the Aschheim-Bajuwarenring cemetery (Bavaria, Germany); these are the oldest pathogen genomes obtained to date. Using these short fragments, the researchers reconstructed the genome of the bacterium responsible, and compared it to a database of genomes of more than a hundred contemporary strains.
The results showed that the bacterium was a strain of Yersinia pestis, the same pathogen responsible for the Black Death. But while the strain responsible for the Justinian outbreak was an evolutionary “dead-end” and faded out on its own, the other, likely a descendant of the Black Death strain, lead to another worldwide pandemic spreading from Hong Kong across the globe in the late 1800’s. According to the researchers, these findings suggest a new strain of plague could emerge again in humans in the future. The study was published online on January 28, 2014, in the Lancet Infectious Diseases.
“About 200 rodent species carry the plague and could potentially infect other animals or humans. Scientists need to sharpen their surveillance of plague in rodent populations to try averting future human infections,” said lead author Associate Professor Hendrik Poinar, PhD, director of the McMaster Ancient DNA Center. “If we happen to see a massive die-off of rodents somewhere, then it would become alarming. Plague is something that will continue to happen, but modern-day antibiotics should be able to stop it.”
The Plague of Justinian struck in the sixth century and it is estimated to have killed between 30 and 50 million people—virtually half the world's population—as it spread across Asia, North Africa, The Arabian peninsula, and Europe. The Black Death struck some 800 years later with similar force, killing 50 million Europeans in just four years (1347-1351).
Related Links:
McMaster University
Northern Arizona University
University of Sydney
Latest Microbiology News
- Rapid Host-Response Test Aims to Predict Corticosteroid Benefit in Sepsis
- Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms
- Study Finds Distinct Malaria Parasites Linked to Sickle Cell Trait Protection
- Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis
- Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification
- Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive
- FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample
- One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens
- FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures
- New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment
- Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories
- Study Finds Frequent Overlap in Antibodies to Lyme and Other Tick-Borne Pathogens
- Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk
- FDA Breakthrough-Designated Urine Panel Aims to Shorten Pathogen and Susceptibility Testing
- Expanded Newborn Screening Program Increases Detection of Congenital Cytomegalovirus
- Genetic Studies Uncover Mechanisms Driving Drug Resistance in Superbugs
Channels
Clinical Chemistry
view channel
Multimodal Clinical Data Models Predict Cachexia Risk Across Cancers
Cancer cachexia is a severe wasting syndrome that affects roughly half of patients with cancer and cannot be reversed simply by increasing food intake. It can reduce treatment tolerance, impair quality... Read more
Study Evaluates Alzheimer’s Blood Biomarker Across Racial and Ethnic Groups
Alzheimer’s disease trials increasingly depend on identifying cognitively unimpaired people who already have elevated brain amyloid. Blood biomarkers may help reduce reliance on positron emission tomography... Read moreMolecular Diagnostics
view channel
AI Tool Classifies Pathogenic Variants in Severe Childhood Epilepsy
Developmental and epileptic encephalopathies are rare neurodevelopmental disorders characterized by early-life seizures and significant developmental delays. Genetic testing can identify variants associated... Read more
Noninvasive Cervical Test Detects Endometrial Cancer for Triage
Endometrial cancer is rising in incidence and mortality in the United States. The disease has no population screening program or FDA-cleared noninvasive test for early identification, and evaluation can... Read moreHematology
view channel
New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis
Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read more
Handheld Point-of-Care Test Aims to Enable Rapid Coagulation Assessment in Trauma
Severe blood loss and inadequate tissue oxygenation are leading causes of preventable death after traumatic injury. Blood products are essential in trauma care, but cold-chain storage, short shelf life,... Read moreImmunology
view channel
FDA Approval Adds Automated Testing Option for Parvovirus B19 Serology
Human Parvovirus B19 is a highly contagious erythrovirus transmitted mainly through respiratory droplets and close contact. Diagnosis relies on IgM antibodies to detect active infection and IgG antibodies... Read more
Blood-Based Immune Aging Map Could Help Spot Disease Risk Earlier
Chronological age does not always reflect immune health or future disease risk. Two adults of the same age can have immune systems that age very differently, with some remaining resilient while others... Read moreMicrobiology
view channel
Rapid Host-Response Test Aims to Predict Corticosteroid Benefit in Sepsis
Sepsis and severe infections are difficult to treat because patients with similar clinical presentations may have very different underlying immune responses. Corticosteroids are commonly used in severe... Read more
Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms
Long Covid can involve persistent respiratory, cognitive, and gastrointestinal symptoms after acute infection, creating a difficult diagnostic and management challenge. Because COVID-19 initially affects... Read morePathology
view channel
Molecular Testing Refines Barrett’s Esophagus Progression Risk Beyond Biopsy Findings
Barrett’s esophagus is a precancerous condition associated with increased risk of esophageal adenocarcinoma. Routine endoscopic biopsy findings guide surveillance and therapy, but histopathology may not... Read more
Updated Digital Pathology Platform Expands AI Integration for Cancer Diagnosis
Digital pathology is reshaping how laboratories manage case review, image analysis, and collaboration. As diagnostic workflows become more complex, pathology teams need platforms that can support digital... Read moreTechnology
view channelLaser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. Early detection remains critical, but cancer biomarkers can produce only faint... Read moreIndustry
view channel
Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care
Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more







